The virus shred­der: A Prince­ton spin­out ad­vised by a high-pro­file VC launch­es a Cas13 vi­ral de­fense sys­tem

Cameron Myhrvold is one of those young sci­en­tists who’s been earn­ing dou­ble takes for the cut­ting-edge re­search work he’s been do­ing, even be­fore join­ing Prince­ton in 2020. But af­ter get­ting his PhD in sys­tems bi­ol­o­gy at Har­vard sev­en years ago, he even­tu­al­ly turned to Cas13, a CRISPR ef­fec­tor — Cas9 is the fa­mous one used on DNA — that is tar­get­ed at sin­gle-strand­ed RNA in­stead of dou­ble-strand­ed DNA.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER